These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 35505864)

  • 1. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
    Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D
    Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
    Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
    Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
    Liu Z; Alexander JL; Le K; Zhou X; Ibraheim H; Anandabaskaran S; Saifuddin A; Lin KW; McFarlane LR; Constable L; Seoane RC; Anand N; Bewshea C; Nice R; D'Mello A; Jones GR; Balarajah S; Fiorentino F; Sebastian S; Irving PM; Hicks LC; Williams HR; Kent AJ; Linger R; Parkes M; Kok K; Patel KV; Teare JP; Altmann DM; Boyton RJ; Hart AL; Lees CW; Goodhand JR; Kennedy NA; Pollock KM; Ahmad T; Powell N;
    EClinicalMedicine; 2023 Oct; 64():102249. PubMed ID: 37842172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal Study.
    Liew MY; Mathews JI; Li A; Singh R; Jaramillo SA; Weiss ZF; Bowman K; Ankomah PO; Ghantous F; Lewis GD; Neuringer I; Bitar N; Lipiner T; Dighe AS; Kotton CN; Seaman MS; Lemieux JE; Goldberg MB
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad369. PubMed ID: 37577118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
    Murray SM; Pose E; Wittner M; Londoño MC; Schaub G; Cook J; Dimitriadis S; Meacham G; Irwin S; Lim Z; Duengelhoef P; Sterneck M; Lohse AW; Perez V; Trivedi P; Bhandal K; Mullish BH; Manousou P; Provine NM; Avitabile E; Carroll M; Tipton T; Healy S; Burra P; Klenerman P; Dunachie S; Kronsteiner B; Maciola AK; Pasqual G; Hernandez-Gea V; Garcia-Pagan JC; Lampertico P; Iavarone M; Gines P; Lütgehetmann M; Schulze Zur Wiesch J; Russo FP; Barnes E; Marjot T;
    J Hepatol; 2024 Jan; 80(1):109-123. PubMed ID: 37863203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients.
    Ducasa N; Benencio P; Mauro E; Anders M; Mazzitelli B; Bleichmar L; Quiroga MF; Barbero M; Cairo F; Alter A; Etcheves P; Scarton G; Sobenko N; Biglione M; Mendizabal M
    Vaccine; 2023 Dec; 41(52):7663-7670. PubMed ID: 38007341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous SARS-CoV-2 infection or a third dose of vaccine elicited cross-variant neutralising antibodies in vaccinated solid-organ transplant recipients.
    Chang CC; Vlad G; Vasilescu ER; Li P; Husain SA; Silvia EA; Cohen DJ; Ratner LE; Sun WZ; Mohan S; Suciu-Foca N
    Clin Transl Immunology; 2022; 11(8):e1411. PubMed ID: 35979345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID.
    Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Söderdahl G; Österborg A; Smith CIE; Vesterbacka J; Wullimann D; Cuapio A; Akber M; Bogdanovic G; Muschiol S; Åberg M; Loré K; Sällberg Chen M; Buggert M; Ljungman P; Aleman S; Ljunggren HG
    EBioMedicine; 2023 Aug; 94():104700. PubMed ID: 37453361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients.
    Knell AI; Böhm AK; Jäger M; Kerschbaum J; Engl S; Rudnicki M; Buchwinkler L; Bellmann-Weiler R; Posch W; Weiss G
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients.
    Tauzin A; Beaudoin-Bussières G; Gong SY; Chatterjee D; Gendron-Lepage G; Bourassa C; Goyette G; Racine N; Khrifi Z; Turgeon J; Tremblay C; Martel-Laferrière V; Kaufmann DE; Cardinal H; Cloutier M; Bazin R; Duerr R; Dieudé M; Hébert MJ; Finzi A
    iScience; 2022 Sep; 25(9):104990. PubMed ID: 36035196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study.
    Kim WJ; Choi SH; Park JY; Song JS; Chung JW; Choi ST
    Ann Rheum Dis; 2022 Nov; 81(11):1585-1593. PubMed ID: 35878999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination.
    Underwood AP; Sølund C; Fernandez-Antunez C; Villadsen SL; Mikkelsen LS; Fahnøe U; Bollerup S; Winckelmann AA; Schneider UV; Binderup A; Vizgirda G; Sørensen AL; Vinten CN; Dalegaard MI; Ramirez S; Weis N; Bukh J
    EBioMedicine; 2023 Mar; 89():104475. PubMed ID: 36870117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy.
    Priddey A; Chen-Xu MXH; Cooper DJ; MacMillan S; Meisl G; Xu CK; Hosmillo M; Goodfellow IG; Kollyfas R; Doffinger R; Bradley JR; Mohorianu II; Jones R; Knowles TPJ; Smith R; Kosmoliaptsis V
    Front Immunol; 2023; 14():1296148. PubMed ID: 38259440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.
    Furukawa K; Tjan LH; Kurahashi Y; Sutandhio S; Nishimura M; Arii J; Mori Y
    JAMA Netw Open; 2022 May; 5(5):e2210780. PubMed ID: 35532938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023.
    Solera JT; Árbol BG; Mittal A; Hall V; Marinelli T; Bahinskaya I; Selzner N; McDonald M; Schiff J; Sidhu A; Humar A; Kumar D
    Am J Transplant; 2024 Jul; 24(7):1303-1316. PubMed ID: 38499087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
    Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
    Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.